Takotsubo cardiomyopathy
Background
- AKA transient apical ballooning syndrome or stress-induced cardiomyopathy
Clinical Features
- Mimics Acute Coronary Syndrome
- Chest Pain
- Dyspnea
- Cardiogenic Shock
- Lethal arrhythmia (e.g. VT/VF, PEA)
Differential Diagnosis
ST Elevation
- Cardiac
- ST-segment elevation myocardial infarction (STEMI)
- Post-MI (ventricular aneurysm pattern)
- Previous MI with recurrent ischemia in same area
- Wellens' syndrome
- Coronary artery vasospasm (eg, Prinzmetal's angina)
- Coronary artery dissection
- Pericarditis
- Myocarditis
- Aortic dissection in to coronary
- Left ventricular aneurysm
- Left ventricular pseudoaneurysm
- Early repolarization
- Left bundle branch block
- Left ventricular hypertrophy (LVH)
- Myocardial tumor
- Myocardial trauma
- RV pacing (appears as Left bundle branch block)
- Brugada syndrome
- Takotsubo cardiomyopathy
- AVR ST elevation
- Other thoracic
- Metabolic
- Drugs of abuse (eg, cocaine, crack, meth)
- Hyperkalemia (only leads V1 and V2)
- Hypothermia ("Osborn J waves")
- Medications
Cardiomyopathy
- Dilated cardiomyopathy
- Hypertrophic cardiomyopathy
- Restrictive cardiomyopathy
- Peripartum cardiomyopathy
- Takotsubo cardiomyopathy
- Arrhythmogenic right ventricular dysplasia
Diagnosis
- Troponin frequently elevated
- ECG
- May mimic STEMI
- Frequently affects the anterior distribution and to a lesser extent inferior distribution
- Echocardiogram
- Systolic Dysfunction (with ejection fraction dropping from normal to <25-35%)
- Reduced contractility not explained by single vessel disease
- Angiogram or L Heart Cath
- No occlusive vascular disease identified to explain the event
Management
Supportive care Start by treating as Acute Coronary Syndrome and exclude STEMI Manage arrhythmias as needed Manage Cardiogenic Shock and acute pulmonary edema See Cardiogenic Shock for emergent management Beta Blockers and ACE Inhibitors are commonly used for Takotsuba Anticoagulation may be considered Consider Endotracheal Intubation Consider Intra-aortic balloon pump
Prognosis
Ejection Fraction returns to normal (at least >50%) in nearly all cases (100% in the Sharkey study) Mortality 2% during hospitalization Recurrence in 5-6%
